Fortis Partners with Teleflex for South Asia UroLift Training

India Pharma Outlook Team | Friday, 16 May 2025

 Fortis Partners with Teleflex for South Asia UroLift Training

Fortis Hospitals, Bengaluru, has signed a strategic partnership with Teleflex Incorporated, a world-renowned leader in medical technologies, to set up the UroLift Centre of Education for South Asia. The center will be located at Fortis Hospitals, Bannerghatta Road, Bengaluru, and will function as a training center for the UroLift System, a minimally invasive procedure for benign prostatic hyperplasia (BPH).

The UroLift System provides a new alternative for BPH treatment, a disease that afflicts many men and causes problematic urinary symptoms, productivity loss, sleep disturbance, depression, and compromised quality of life. The UroLift System differs from other treatments in that it does not cut, heat, or take out prostate tissue. It provides quick symptom relief and maintains sexual function and generally obviates catheterization after treatment.

Dr. Ashutosh Raghuvanshi, MD & CEO, Fortis Healthcare Limited, said, "The healthcare landscape continues to evolve, and more minimally invasive therapies continue to emerge. At Fortis, we always strive to offer superior technologies to our patients. This educational initiative in association with Teleflex is another testament to our commitment to quality patient care."

Teleflex views this association as a platform to raise the level of clinical standards. "We believe that education is the foundation of progress in healthcare. Our collaboration with Fortis Hospitals will empower medical professionals with advanced knowledge and hands-on training, ultimately improving patient care," said Arun Kaushik, managing director, South Asia, Teleflex.

Echoing the same vision, Dr. Mohan Keshavamurthy, principal director, renal sciences, Fortis Hospitals, Bengaluru, added, " Through this collaboration, we are committed to helping urologists acquire requisite skill to optimize individualized treatment solutions such as UROLIFT for patients requiring Endoscopic surgical solutions for BPH and enhancing outcomes thereof. The program is designed to provide a comprehensive training program to urologists to ensure careful selection and safe delivery of UROLIFT System to patients in their practice."

© 2025 India Pharma Outlook. All Rights Reserved.